Key result
Prednisone, vasodilators, and stapokibart prompt marked regression of left main coronary narrowing in severe atopy.
Why the study?
Newly detected coronary narrowing after PCI is usually attributed to atherosclerosis progression, stent complications, or vasomotor abnormalities, whereas immune-inflammatory mechanisms contributing to dynamic and reversible coronary lesions are less commonly considered.
Case Report (n=1)
No
Dynamic left main coronary artery narrowing in patients with severe atopic disease and hyper-IgE may result from reversible immune-inflammatory or vasomotor mechanisms rather than fixed atherosclerotic progression, responding to immunosuppressive and vasodilator therapy without repeat revascularization.
Answers are grounded in this paper and cite their sources.
Does not warrant practice changes; hypothesis-generating for immune-mediated coronary narrowing in atopic disease and needs prospective validation.
Background Newly detected coronary narrowing after percutaneous coronary intervention (PCI) is usually attributed to progression of atherosclerosis, stent-related complications, or coronary vasomotor abnormalities. Immune-inflammatory mechanisms are less commonly considered but may contribute to dynamic and potentially reversible coronary lesions. Case presentation A 74-year-old man with hypertension, dyslipidemia, a history of heavy smoking, severe atopic dermatitis (AD), persistently and markedly elevated serum total IgE, and previous membranous nephropathy presented with recurrent chest tightness and chest pain. He had previously undergone drug-eluting stent implantation in the mid left anterior descending artery. Several months later, coronary computed tomography angiography (CCTA) demonstrated a patent stent but newly developed left main (LM) coronary artery narrowing. Electrocardiography and cardiac biomarkers showed no evidence of acute myocardial injury. Laboratory evaluation revealed serum total IgE levels persistently exceeding 5,000 IU/mL, mildly elevated high-sensitivity C-reactive protein, and weak p-ANCA positivity, without marked peripheral eosinophilia. PET/CT showed no abnormal metabolic activity at the coronary stent site or calcified coronary plaques, but demonstrated inflammatory activity in the infrarenal abdominal aorta and bilateral common iliac arteries. In view of the dynamic coronary findings and the prominent allergic-inflammatory background, an immune-mediated vascular process was considered, and immediate repeat revascularization was deferred. The patient was treated with prednisone followed by gradual tapering, together with standard cardiovascular and vasodilator therapy. Stapokibart was subsequently initiated for recurrent atopic dermatitis after an allergy specialist raised the possibility of eosinophilic granulomatosis with polyangiitis (EGPA). Follow-up CCTA demonstrated marked regression of the LM narrowing. Conclusion This case describes a dynamic LM coronary narrowing in a patient with severe atopic disease, marked hyper-IgE, and systemic inflammatory features. The marked interval change on serial coronary imaging raises the possibility of transient vasomotor or immune-inflammatory mechanisms rather than rapidly progressive fixed atherosclerotic stenosis alone.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a case report in Left main coronary artery narrowing with severe atopic dermatitis and elevated serum IgE (n=1). Prednisone, stapokibart, and vasodilator therapy was evaluated on Regression of left main coronary artery narrowing on follow-up CCTA. Prednisone, vasodilator therapy, and stapokibart led to marked regression of left main coronary artery narrowing in a 74-year-old man with severe atopic dermatitis and serum IgE >5,000 IU/mL.
Synapse has enriched 10 related papers. Consider them for comparative context: